Anavex Life Sciences Corp (AVXL)

[Amatuer17]

If A2-73 is better than Aduc - well if Anavex shows in the trials, it will automatically be a leader.

To do that - AVXL has to finish the current trial (which is 18 months away) then assuming good results start another large (like 500-1000 patients) phase 3 trial - which will take another 30-36 months minimum - prove that it works on larger population and then get approval.

Well add all timelines and you have 4 years away from approval at minimum.

In the meantime BIIB will earn $3 B per year. Well market knows how to make money.